Novo Nordisk A/Ss shares fell by the most on record after patients using its experimental obesity shot CagriSema lost less weight than predicted in a study, throwing into question the drugmakers abil… [read more]
Novo Nordisk Falls Most on Record After New Weight Drug Disappoints – Bloomberg
Date: